Trials / Completed
CompletedNCT02431377
Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula
Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 21 Days – 35 Days
- Healthy volunteers
- Accepted
Summary
A single center, non-controlled trial to document the gastrointestinal (GI) tolerability of the study formula (SF), containing a whey protein concentrate enriched with alpha-lactalbumin (WPC alpha-lac) fed for 6 weeks to healthy, term infants.
Detailed description
The purpose of this study is to examine the tolerable and acceptability of an infant formula with with a Whey protein concentrate containing alpha-lactalbumin as measure by GI tolerance, and eating behaviors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | S-26 Gold | A commercial whey protein dominant, first age formula, containing whey protein concentrate with alpha-lactalbumin |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-09-01
- Completion
- 2015-10-01
- First posted
- 2015-05-01
- Last updated
- 2015-11-03
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT02431377. Inclusion in this directory is not an endorsement.